Champions Oncology, Inc. Common Stock (CSBR)

Typically moves ±4.22% on earnings
EARNINGS ANALYTICS
event_upcoming Next Earnings: 2026-12-11 HIGH CONFIDENCE
search

Since Sep 13, 2021, Champions Oncology, Inc. Common Stock (CSBR) has reported earnings 15 times. On average the shares move ±4.22% post-earnings, with a positive reaction 66.7% of the time. Its largest post-earnings gain was +10.7% (Mar 15, 2022) and its largest decline was -10.19% (Dec 11, 2024). The next earnings report is predicted for 2026-12-11 (high confidence).

Earnings reactions

How CSBR moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

15

Avg Abs. Movement

±4.22%

Positive %

66.7%

Negative %

33.3%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Jul 27, 2026 ☽ POST +0.35% open_in_new
Mar 12, 2026 ☽ POST +0% open_in_new
Dec 15, 2025 ☽ POST -1.26% open_in_new
Sep 15, 2025 ☽ POST +0% open_in_new
event

Earnings Count

15

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.22%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 8 →
8
Funds holding
$4035154
Total value held
Buying
3 added · 2 reduced
Morgan Stanley
$1450064 -2.85%
Bank Of America Corp /De/
$1318597 +880.43%
Blackrock, Inc.
$799864 +4.80%
Northern Trust Corp
$171926 -39.24%
State Street Corp
$161410 Held

Frequently asked about CSBR earnings

When does Champions Oncology, Inc. Common Stock report earnings next? expand_more

Champions Oncology, Inc. Common Stock (CSBR)'s next earnings date is predicted (high confidence) for 2026-12-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CSBR stock move after earnings? expand_more

Over 15 reports, CSBR has moved an average of ±4.22% the session after earnings, closing higher 66.7% of the time.

What was CSBR's biggest post-earnings move? expand_more

CSBR's largest post-earnings gain on record was +10.7% on Mar 15, 2022, and its largest decline was -10.19% on Dec 11, 2024.

Where can I find Champions Oncology, Inc. Common Stock's SEC filings? expand_more

All of Champions Oncology, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.